Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-022309
Filing Date
2025-08-19
Accepted
2025-08-19 16:30:14
Documents
1
Period of Report
2025-08-15

Document Format Files

Seq Description Document Type Size
1 form4-08192025_040801.html 4  
1 form4-08192025_040801.xml 4 7836
  Complete submission text file 0001415889-25-022309.txt   9370
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Business Address
Boulding Mark Elliott (Reporting) CIK: 0001578852 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 251232210